William Barrett, MD
Co-Director, University of Cincinnati Cancer Center, Chairman and Professor, Department of Radiation Oncology, Medical Director, UC Health Barrett Cancer Center
William Barrett, MD, is Co-Director of the University of Cincinnati Cancer Center, Professor and Chair of the Department of Radiation Oncology at the UC College of Medicine, and Medical Director of the UC Health Barrett Cancer Center.
Dr. Barrett received his undergraduate degree from the University of Virginia, and his medical degree from UC. His training included an internship in general surgery at UC followed by residency in radiation oncology at UC, and a fellowship in brachytherapy at Memorial Sloan-Kettering Cancer Center.
He has been on the faculty at UC since 1992, and has experience in treating patients with most types of cancers. Dr. Barrett 's areas of particular interest include cancer of the prostate, cancer of the head and neck, and the use of radiation seeds as well as external radiation therapy for a number of cancers. He focuses on cancer education for the general public as well as physicians in the greater Cincinnati area, and has organized a number of educational conferences in addition to being very involved in medical student and resident education at the university.
Syed Ahmad, MD
The Hayden Family Endowed Chair for Cancer Research, Co-Director, University of Cincinnati Cancer Center Professor, Department of Surgery, Director, UC Health Pancreatic Disease Center and, Director, Division of Surgical Oncology
Syed Ahmad, MD, is Co-Director of the University of Cincinnati Cancer Center, and is Professor of Surgery at the UC College of Medicine. Dr. Ahmad graduated from Duke University, and then the University of Maryland School of Medicine in 1992. He completed his residency at Pennsylvania Hospital in Philadelphia in 1998. During residency, he also completed a post-doctoral research fellowship at the Johns Hopkins Medical Institutions. He subsequently completed both a Research Fellowship and a clinical Complex Surgical Oncology Fellowship at the University of Texas M.D. Anderson Cancer Center in Houston before joining the UC surgical faculty in 2001. Dr. Ahmad became Director of the UC Pancreatic Disease Center in 2007, and Director of the Division of Surgical Oncology in 2015.
A nationally recognized leader in oncologic surgery for pancreas and hepatobiliary cancers, his research interests include novel translational research for GI malignancies. He currently serves as the Principal Investigator on two NCI designated cooperative studies (SWOG 1505 and Alliance 021501). These studies are investigating therapies for resectable and borderline resectable pancreas cancers. He is the co-PI on several NCI funded research grants. He has published over 200 articles and chapters and recently edited a textbook entitled Locally Advanced and Borderline Resectable Pancreas Cancer. Dr. Ahmad also plays a major role within the Southwest Oncology Group serving as the Chair of the Surgery Subcommittee. He serves as a reviewer for 15 prestigious clinical and research journals, is Associate Editor for the Journal of Gastrointestinal Cancers, and the Journal of Gastrointestinal Surgery, and serves on the editorial boards of five journals. Dr. Ahmad is a member of many prestigious national medical societies and has served in leadership roles in many of these societies.
Joseph Steven Price, MBA (Steve)
Associate Administrative Director, University of Cincinnati Cancer Center
Steve Price joined the University of Cincinnati Cancer Center as Associate Director for Administration in 2018. In this role, he supports faculty, staff, and leaders at the University of Cincinnati, Children’s Hospital Medical Center, and UC Health in further developing programs and administrative infrastructures necessary to increase cancer-related trans-disciplinary research and collaboration at the three institutions.
Steve hails from the Wake Forest School of Medicine (WFSOM) in Winston-Salem, NC, where he held key administrative positions. His roles included Director of Clinical Research Management, Associate Director of Finance and Administration, then Director of Finance and Operations in the Comprehensive Cancer Center of Wake Forest University (NCI designated). Steve received a BSBA from the Kenan-Flagler School of Business at UNC-Chapel Hill, and MBA from the Babcock Graduate School of Management at Wake Forest.
Thomas Herzog, MD
Clinical Deputy Director, University of Cincinnati Cancer Center, Professor, Department of Obstetrics and Gynecology
Thomas Herzog, MD, is Clinical Deputy Director of the University of Cincinnati Cancer Center, and is Professor of obstetrics and gynecology at the UC College of Medicine.
Dr. Herzog graduated from the UC College of Medicine in 1986, and completed his residency at Good Samaritan Hospital in Cincinnati in 1990. He completed a fellowship in gynecologic oncology at the Washington University School of Medicine in St. Louis in 1993, before becoming a faculty member at Washington University, and then director of its gynecologic oncology fellowship program. In 2004, he became the director of the division of gynecologic oncology at Columbia University in New York.
Dr. Herzog is a National Institutes of Health- and American Cancer Society-funded researcher who has published more than 200 peer-reviewed manuscripts. He has served as a member of several professional societies including the American College of Surgeons, for which he is also on the elected board of governors, the American Board of Obstetrics and Gynecology and the American Society for Colposcopy and Cervical Pathology, among others. Dr. Herzog is also editor-in-chief of Gynecologic Oncology Research and Practice and serves on the editorial boards for a number of other peer-reviewed journals.
Pier Paolo Scaglioni, MD
Director, Division of Hematology/Oncology, University of Cincinnati
Pier Paolo Scaglioni, MD, is the Herbert F. Koch Professor of Medicine, and the Director of the Division of Hematology/Oncololgy. Dr. Scaglioni received his medical degree from the University of Modena Medical School in Italy in 1989, and completed his Hematology/Oncology fellowship at Memorial Sloan Kettering Cancer Center, New York City, NY, in 2005.
Dr. Scaglioni specializes in malignant hematology, and is currently the Interim Director of the George L Strike Bone Marrow Transplant Program at the University of Cincinnati.
Dr. Scaglioni also leads a research laboratory which consists of 2 post-doc fellows, a visiting Scholar, and a Senior Research Associate. His team is currently studying the effect of KRAS in non-small cell lung cancer.
Jun-Lin Guan, PhD
Basic Science Research Director, University of Cincinnati Cancer Center
Jun-Lin Guan, PhD, Francis Brunning Endowed Chair, and Professor of Cancer Biology, received his PhD at the University of California at San Diego in 1987. After postdoctoral training at the Center for Cancer Research at the Massachusetts Institute of Technology, Dr. Guan joined Cornell University faculty as an Assistant Professor in 1991, where he became a full Professor in 2001. He became a faculty member at the University of Michigan Medical School in 2006, and finally joined the UC faculty in 2014.
Dr. Guan's research centers on the mechanisms of cell signaling in biological processes and how disruption of the normal signaling pathways leads to cancer and other diseases. He is world renowned for his work on focal adhesion kinase (FAK), an important cytoplasmic signaling enzyme that impacts a wide range of normal physiology and pathology.
Trisha Wise-Draper, MD, PhD
Medical Director, University of Cincinnati Cancer Center Clinical Trials Office
Trisha Wise-Draper, MD, PhD, Assistant Professor in the Division of Hematology Oncology in the Department of Internal Medicine, received her MD/PhD from the University of Cincinnati, and completed her residency at the University of Cincinnati Medical Center.
Dr. Wise-Draper 's research focuses on translational mechanisms of therapeutic resistance and biomarkers in cancer, particularly head and neck cancer. Specifically, she is interested in identifying mechanisms important for immunotherapy resistance including T cell dysfunction, the role of macrophages, and possible signaling pathways involved. She is also involved with the Experimental Phase I Therapeutics Program.
Michelle Marcum, MS, CCRP
Administrative Director, University of Cincinnati Cancer Center Clinical Trials Office
Michelle Marcum joined the University of Cincinnati Cancer Center as Director of the Cancer Clinical Trials Office in 2019. In her role, Michelle oversees the operations of the clinical trials office and works closely with University of Cincinnati Cancer Center leadership and the University of Cincinnati Cancer Center Clinical Trials Office Medical Director to develop and maintain a clinical research infrastructure poised to conduct interdisciplinary cancer clinical research of the highest quality. Michelle received her B.S. from Pennsylvania State University and M.S. from Drexel University.
Ken Greis, PhD
Core Facilities Director, University of Cincinnati Cancer Center
Ken Greis, PhD, is a Professor in the Department of Cancer Biology. He received his PhD from the University of Kentucky in 1991, and completed post-doctoral training at Johns Hopkins School of Medicine in 1993, and the University of Alabama at Birmingham in 1996.
Dr. Greis is in charge of the UC Proteomics Laboratory within the Department of Cancer Biology. Proteomics is the large-scale analysis of protein expression patterns. Along with functional genomics, proteomics is now an established tool for investigators to better understand the molecular events underlying many biological processes. The laboratory is equipped with protein separation and mass spectrometry equipment as well as trained personnel to perform comparative analyses of complex protein mixtures and to identify the deferentially-expressed proteins.
Dr. Greis' research is dedicated toward integrating mass spectrometry-based technology to understand biological systems. He collaborates with many investigators across the University of Cincinnati, Cincinnati Children's Hospital Medical Center, and outside institutions and businesses. Currently, his two primary research focuses are in the area of quantitative phosphorylation profiling and the use of mass spectrometry for enzyme assays, and high throughput inhibitor screening.